Abstract
Prostate-specific membrane antigen (PSMA) is considered a significant target for the diagnosis and therapy of prostate cancer. 2-[3-(1,3-dicarboxypropyl)-ureido]pentanedioic acid (DUPA) is a promising binding motif that has been proved to target PSMA successfully. 3-Hydroxy-4-pyridinone units containing multidentate bifunctional chelators could chelate gallium(III) at mild conditions effectively. In this letter, we combine DUPA with a tris(hydroxypyridinone) bifunctional chelator and get a novel precursor of gallium-68 radiopharmaceutical, DUPA-β-Ala-KC18. The synthesis, characterization of DUPA-β-Ala-KC18 and the formation of its natural-abundance gallium(III) complex are presented. DUPA-β-Ala-KC18 displayed a binding affinity to PSMA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
